4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-23-031002
Options or other derivatives
- Director acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| CLARKE JOHN K Director | 2023-05-17 | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | D | ||
Loading xslF345X04/doc4.xml…